Explore the Potential with AI-Driven Innovation
The specialised, focused library is developed on demand with the most recent virtual screening and parameter assessment technology, guided by the Receptor.AI drug discovery platform. This approach exceeds the capabilities of traditional methods and offers compounds with higher activity, selectivity, and safety.
We carefully select specific compounds from a vast collection of over 60 billion molecules in virtual chemical space. Our partner Reaxense helps in synthesizing and delivering these compounds.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
We use our state-of-the-art dedicated workflow for designing focused libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our methodology leverages molecular simulations to examine a vast array of proteins, capturing their dynamics in both isolated forms and in complexes with other proteins. Through ensemble virtual screening, we thoroughly account for the protein's conformational mobility, identifying critical binding sites within functional regions and distant allosteric locations. This detailed exploration ensures that we comprehensively assess every possible mechanism of action, with the objective of identifying novel therapeutic targets and lead compounds that span a wide spectrum of biological functions.
Our library stands out due to several important features:
partner
Reaxense
upacc
Q93097
UPID:
WNT2B_HUMAN
Alternative names:
Protein Wnt-13
Alternative UPACC:
Q93097; O14903; Q5TEH9; Q5TEI2; Q9HDC1; Q9HDC2
Background:
Protein Wnt-2b, also known as Protein Wnt-13, plays a pivotal role in the canonical Wnt/beta-catenin signaling pathway. It is a ligand for members of the frizzled family of seven transmembrane receptors and has a redundant role in embryonic lung development.
Therapeutic significance:
Protein Wnt-2b is implicated in Diarrhea 9, an autosomal recessive chronic diarrhea disorder. Understanding the role of Protein Wnt-2b could open doors to potential therapeutic strategies for this condition.